0001209191-19-021361.txt : 20190326 0001209191-19-021361.hdr.sgml : 20190326 20190326183927 ACCESSION NUMBER: 0001209191-19-021361 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190325 FILED AS OF DATE: 20190326 DATE AS OF CHANGE: 20190326 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gujrathi Sheila CENTRAL INDEX KEY: 0001575202 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38796 FILM NUMBER: 19706279 MAIL ADDRESS: STREET 1: 10835 ROAD TO THE CURE STREET 2: SUITE 205 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Gossamer Bio, Inc. CENTRAL INDEX KEY: 0001728117 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 475461709 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3013 SCIENCE PARK CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (858) 922-0718 MAIL ADDRESS: STREET 1: 3013 SCIENCE PARK CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-03-25 0 0001728117 Gossamer Bio, Inc. GOSS 0001575202 Gujrathi Sheila 3013 SCIENCE PARK ROAD SAN DIEGO CA 92121 1 1 0 0 President & CEO Stock Option (right to buy) 22.10 2019-03-25 4 A 0 380000 0.00 A 2029-03-25 Common Stock 380000 380000 D 25% of the total number of shares subject to the option will vest on March 25, 2020 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Corporation on each such vesting date. /s/ Jeff Boerneke, Attorney-in-Fact 2019-03-26